Concepedia
Statistics
Publications
39
Citations
2.6K
H-Index
29
Active since
1990
Affiliations
Affimed Therapeutics (Germany)(Current)
University of the Witwatersrand
Ludwig-Maximilians-Universität München
German Cancer Research Center
Heidelberg University
Uwe Reusch is an author at Affimed Therapeutics (Germany) specializing in medicine, immunology, and cell biology.
Top concepts
MedicineImmunologyCell BiologyImmunotherapyTumor BiologyTumor ImmunityCancer ResearchRadiation OncologyTumor MicroenvironmentOncology
Publications per year
1990–2022
Natural Killer Cells Activated by MHC Class ILow Targets Prime Dendritic Cells to Induce Protective CD8 T Cell Responses
Ralph Mocikat, Heidi Braumüller, Alain Gumy et al. · Immunity · 2003 · 418 citations · Full text
Inflammation, Allergy, Autoimmune Disease +8
A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation
Uwe Reusch, Walter Muranyi, Pero Lučin et al. · The EMBO Journal · 1999 · 248 citations · Full text
Virus Structure, Viral Replication, Molecular Virology +9
A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30<sup>+</sup>tumor cells
Uwe Reusch, Carmen Burkhardt, Ivica Fucek et al. · mAbs · 2014 · 158 citations · Full text
Immunology, Nk Cells, Immunologic Mechanism +18
CD16A Activation of NK Cells Promotes NK Cell Proliferation and Memory-Like Cytotoxicity against Cancer Cells
Jens Pahl, Joachim Koch, Jana-Julia Götz et al. · Cancer Immunology Research · 2018 · 127 citations
A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19<sup>+</sup>tumor cells
Uwe Reusch, Johannes Duell, Kristina Ellwanger et al. · mAbs · 2015 · 125 citations · Full text
Immunology, Immunoediting, Immunologic Mechanism +17
1–5 of 39